| Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
|---|---|---|---|---|---|---|
|
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + sfrp5 MO + Go 6850
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + sfrp5 MO + NSC 23766
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + sfrp5 MO + SP600125
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.e
Li Y et al. (2008) |
Xla Wt + sfrp5 MO + Y27632
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + wnt11b
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.e
Li Y et al. (2008) |
Xla Wt + wnt5a
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.e
Li Y et al. (2008) |
Xla Wt + wnt8a
NF35/36 (in situ hybridization) |
|
|||
|
|
fig 6.e
Li Y et al. (2008) |
Xla Wt + dndvl2-GFP + sfrp5 MO
NF35/36 (in situ hybridization) |
|
|||
|
Fig.1.B
McLin VA et al. (2007) |
Xla Wt + ctnnb1tm1
NF35/36 (in situ hybridization) |
||||
|
|
Fig.1.B
McLin VA et al. (2007) |
Xla Wt + dkk1
NF35/36 (in situ hybridization) |